(NASDAQ: IMNN), a clinical-stage company focused on developing non-viral DNA-mediated immunotherapy and evaluating an adaptation of the platform’s potential as a next-generation vaccine, today ...

IMUNON (IMNN) announced new safety and immunogenicity data from ongoing analyses of results from the Company’s first Phase 1 proof-of-concept ...

The following is a summary of “Biomarker states and risk of death among individuals hospitalized with SARS-CoV-2 infection,” published in the February 2025 issue of BMC Infectious Diseases by ...

Doctor of Biological Sciences, Russian professor-virologist Alexander Shestopalov commented on reports of a new coronavirus ...

Scientists in China have found a new coronavirus in bats that could possibly infect humans, but the risk remains low for now.

Scientists at the Wuhan Institute of Virology in China have discovered a new lineage of a coronavirus in bats that can enter ...

NEW YORK – After acquiring Lucira Health in a bankruptcy auction in 2023, Pfizer has decided to shut down the business, a Pfizer spokesperson told GenomeWeb.

Long COVID is the chronic manifestation of lasting symptoms of SARS-CoV-2 infection that can last for at least 3 months, with shortness of breath and system inefficiency often remaining central issues ...

Hospitalisations and deaths attributed to COVID have dropped significantly since a peak in 2022. But a new variant could ...

HKU5-CoV-2 has sparked concerns because it can spread to humans in a similar way to the one that caused the COVID-19 pandemic ...

A team of Chinese researchers, led by 'batwoman' Shi Zhengli discovered a new bat coronavirus HKU5-Cov-2 which could ...

Anxiety and mood disorders are more prevalent among patients after COVID-19 critical illness vs after severe pneumonia unrelated to COVID-19.